BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colombo M. Hepatitis C virus and hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 1999;13:519-28. [DOI: 10.1053/bega.1999.0045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 El-serag H, Kramer JR. Hepatitis C infection: Dying with or from the infection? Journal of Hepatology 2008;48:183-4. [DOI: 10.1016/j.jhep.2007.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Jiang YF, He B, Li NP, Ma J, Gong GZ, Zhang M. The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-κB pathways. Cell Biol Int 2011;35:1225-32. [PMID: 21612579 DOI: 10.1042/CBI20110102] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
3 Potthoff A, Witte T, Rifai K, Hoy L, Deterding K, Feyerabend S, Manns MP, Wedemeyer H. Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome. Scand J Gastroenterol. 2009;44:994-1003. [PMID: 19462335 DOI: 10.1080/00365520902929864] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
4 El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36:S74-S83. [PMID: 12407579 DOI: 10.1053/jhep.2002.36807] [Cited by in Crossref: 34] [Cited by in F6Publishing: 135] [Article Influence: 1.7] [Reference Citation Analysis]
5 Dore MP, Realdi G, Mura D, Graham DY, Sepulveda AR. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci. 2002;47:1638-1643. [PMID: 12141829 DOI: 10.1023/a:1015848009444] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
6 Douglas DN, Kneteman NM. Generation of improved mouse models for the study of hepatitis C virus. Eur J Pharmacol 2015;759:313-25. [PMID: 25814250 DOI: 10.1016/j.ejphar.2015.03.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
7 El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35:S72-S78. [PMID: 12394209 DOI: 10.1097/00004836-200211002-00002] [Cited by in Crossref: 440] [Cited by in F6Publishing: 421] [Article Influence: 23.2] [Reference Citation Analysis]
8 Young AM, Crosby RA, Oser CB, Leukefeld CG, Stephens DB, Havens JR. Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia. J Med Virol 2012;84:1376-87. [PMID: 22825816 DOI: 10.1002/jmv.23252] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
9 Kovach SJ, Sitzmann JV, Mckillop IH. Inhibition of alcohol dehydrogenase blocks enhanced Gi-protein expression following ethanol treatment in experimental hepatocellular carcinoma in vitro: . European Journal of Gastroenterology & Hepatology 2001;13:1209-16. [DOI: 10.1097/00042737-200110000-00014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
10 Selimovic D, El-Khattouti A, Ghozlan H, Haikel Y, Abdelkader O, Hassan M. Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies. World J Hepatol 2012; 4(12): 342-355 [PMID: 23355912 DOI: 10.4254/wjh.v4.i12.342] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
11 Nourbakhsh M, Douglas DN, Pu CH, Lewis JT, Kawahara T, Lisboa LF, Wei E, Asthana S, Quiroga AD, Law LM. Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production. J Hepatol. 2013;59:336-343. [PMID: 23542347 DOI: 10.1016/j.jhep.2013.03.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
12 Liang M, Wang L, Ma C, Zhang M, Xie G. Sandwich Immunoassay for Hepatitis C Virus Non-Structural 5A Protein Using a Glassy Carbon Electrode Modified with an Au-MoO 3 /Chitosan Nanocomposite. Analytical Letters 2013;46:1241-54. [DOI: 10.1080/00032719.2012.755684] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 el-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001;5:87-107, vi. [PMID: 11218921 DOI: 10.1016/s1089-3261(05)70155-0] [Cited by in Crossref: 222] [Cited by in F6Publishing: 72] [Article Influence: 10.6] [Reference Citation Analysis]
14 Hashimoto K, Mori N, Tamesa T, Okada T, Kawauchi S, Oga A, Furuya T, Tangoku A, Oka M, Sasaki K. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Mod Pathol 2004;17:617-22. [DOI: 10.1038/modpathol.3800107] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 4.2] [Reference Citation Analysis]
15 Benedetto ND, Peralta M, Alvarez E, Schroder MT, Estepo C, Paz S, Fainboim H. Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011. Annals of Hepatology 2014;13:38-44. [DOI: 10.1016/s1665-2681(19)30902-0] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA, Zignego AL. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis. 2007;39 Suppl 1:S13-S21. [PMID: 17936215 DOI: 10.1016/s1590-8658(07)80005-3] [Cited by in Crossref: 72] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
17 Kramer JR, Giordano TP, Souchek J, Richardson P, Hwang LY, El-Serag HB. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol. 2005;100:56-63. [PMID: 15654781 DOI: 10.1111/j.1572-0241.2005.40670.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 108] [Article Influence: 6.3] [Reference Citation Analysis]
18 El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36:S74-S83. [PMID: 12407579 DOI: 10.1002/hep.1840360710] [Cited by in Crossref: 195] [Cited by in F6Publishing: 127] [Article Influence: 9.8] [Reference Citation Analysis]
19 Dore MP, Realdi G, Mura D, Graham DY, Sepulveda AR. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci. 2002;47:1638-1643. [PMID: 12141829 DOI: 10.1023/A: 1015848009444] [Cited by in F6Publishing: 1] [Reference Citation Analysis]